LG

Leena Gogia

Active Director Director DIN 09178321
DIN 09178321 First appointment May 2021 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2021
Shareholding value •••• Premium profile

About Leena Gogia

Data last updated:

Leena Gogia is a Director at Hans Healthcare Private Limited (since 2021). The company operates in Healthcare. Hans Healthcare Private Limited reported revenue of ₹4.03 Cr (FY 2025).

DIN 09178321
Primary Designation Director
Industry Healthcare
First Appointment 19 May 2021
Oldest Company Age 5 yrs
Largest company Hans Healthcare Private Limited · ₹4.03 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hans Healthcare Private Limited U33100DL2021PTC381258
Director19 May 20212021₹4.03 Cr (FY 2025)Active

Board colleagues of Leena Gogia

NameDINCompanyDesignation
Dimple Gogia07729930Hans Healthcare Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hans Healthcare Private Limited
Premium access

Shareholding and investment profile for Leena Gogia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Leena Gogia

Leena Gogia currently holds 1 directorship: Hans Healthcare Private Limited (Director, since 19 May 2021, revenue ₹4.03 Cr (FY 2025)).

Leena Gogia was first appointed on 19 May 2021 as Director at Hans Healthcare Private Limited.

The current boards of Leena Gogia's companies include Dimple Gogia (Hans Healthcare Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available